Abstract Search

ea0035p684 | Male reproduction | ECE2014

The effects of improving testosterone levels on cardiovascular risk markers in young men with idiopathic hypogonadotropic hypogonadism: preliminary findings from a prospective study

Dogan Bercem Aycicek , Karakilic Ersen , Tuna Mazhar Muslum , Arduc Ayse , Berker Dilek , Guler Serdar

Association between idiopathic hypogonadotropic hypogonadism (IHH) and atherosclerotic disease in young males remains unclear. The present study aimed to determine the effect of improving the testosterone level on cardiovasculary (CV) risk markers in young males with IHH.Materials and methods: The study included 19 non-obese males with IHH and 17 healthy controls. The patients were treated with hCG therapy (n=8) or testosterone replacement (...

0 shares

ea0022p664 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Comparison of efficacy of cabergoline and bromocriptine retrospectively in patients with hyperprolactinemia

Isik Serhat , Berker Dilek , Tutuncu Yasemin , Ozuguz Ufuk , Arduc Ayse , Akbaba Gulhan , Aydin Yusuf , Guler Serdar

Objective: Patients with hyperprolactinemia who require medical therapy are typically treated with dopamine agonists (DA). In most cases, medical therapy with DA normalizes the level of prolactin (PRL), restores gonadal function and fertility, and substantially reduces the size of the tumor. Here, we aimed to compare the efficacy of cabergoline (CAB) and bromocriptine (BRC) in hyperprolactinemic patients retrospectively.Methods: Retrospective analysis of...

0 shares

Endocrine Abstracts

The effects of improving testosterone levels on cardiovascular risk markers in young men with idiopathic hypogonadotropic hypogonadism: preliminary findings from a prospective study

Comparison of efficacy of cabergoline and bromocriptine retrospectively in patients with hyperprolactinemia

BiosciAbstracts